Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Anthos Therapeutics
Anthos Therapeutics
Anthos hails win over Xarelto with novel anticoagulant
Anthos hails win over Xarelto with novel anticoagulant
Pharmaphorum
Anthos Therapeutics
clinical trials
abelacimab
Xarelto
anticoagulants
atrial fibrillation
Flag link:
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
FDA grants fast track designation for Anthos’ cancer associated thrombosis therapy
Pharmaceutical Business Review
Anthos Therapeutics
Factor XI inhibitor
abelacimab
fast track
FDA
cancer
Flag link:
Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding
Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding
BioSpace
Anthos Therapeutics
anticoagulants
Flag link:
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
CP Wire
Blackstone Life Sciences
Anthos Therapeutics
Novartis
MAA868
thromboembolism
Flag link:
Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Cardiovascular Disease Treatments
Blackstone Life Sciences
Anthos Therapeutics
Novartis
MAA868
thromboembolism
Flag link:
